Login to your account

Username *
Password *
Remember Me
RCT: Molnupiravir reduced the risk of hospitalization or death in at-risk (i.e., obesity, over 60 years, etc.) unvaccinated adults with Covid-19.

RCT: Molnupiravir reduced the risk of hospitalization or death in at-risk (i.e., obesity, over 60 years, etc.) unvaccinated adults with Covid-19.

Bibliographie
17 décembre 2021
Soyez le premier à commenter!

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients – New England Journal of Medicine Related: Merck’s COVID pill loses its lustre: what that means for the pandemic – Nature (several articles on the subject)  

The post RCT: Molnupiravir reduced the risk of hospitalization or death in at-risk (i.e., obesity, over 60 years, etc.) unvaccinated adults with Covid-19. appeared first on Links Medicus.

Lu 559 fois
Évaluer cet élément
(0 Votes)
Plus dans cette catégorie : « Randomized trial with nearly 30.000 individuals showed Novavax vaccine was safe and had an overall efficacy of 90.4% against symptomatic infections. RCT: Among patients hospitalized with COVID-19 at increased risk for venous thromboembolism, post-discharge thromboprophylaxis with Rivaroxaban for 35 days may improve outcomes. »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.

Retour en haut

Search